Redhill Biopharma Ltd banner

Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.7447 USD -0.71% Market Closed
Market Cap: $3.8m

Wall Street
Price Targets

RDHL Price Targets Summary
Redhill Biopharma Ltd

There are no price targets for RDHL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Redhill Biopharma Ltd Competitors:
Price Targets
ALKS
Alkermes Plc
47% Upside

Revenue
Forecast

84% / Year
Past Growth
382% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
84% / Year
Past Growth
382% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 11 years the compound annual growth rate for Redhill Biopharma Ltd's revenue is 84%. The projected CAGR for the next 1 year is 382%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RDHL's stock price target?
Not Available

RDHL doesn't have any price targets made by Wall Street professionals.

What is Redhill Biopharma Ltd's Revenue forecast?
Projected CAGR
382%

For the last 11 years the compound annual growth rate for Redhill Biopharma Ltd's revenue is 84%. The projected CAGR for the next 1 year is 382%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett